CAITLYN SCHALLER: Open Payments
NPI 1235529983 · PETOSKEY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,240 in 179 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $4,009 · 2025 $4,240
Food & beverage: $3,947Education: $293
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 26 | $788 |
| GlaxoSmithKline, LLC. | 39 | $589 |
| Inspire Medical Systems, Inc. | 8 | $473 |
| Verona Pharma, Inc. | 24 | $422 |
| Insmed, Inc. | 17 | $413 |
| GENZYME CORPORATION | 9 | $274 |
| Actelion Pharmaceuticals US, Inc. | 9 | $271 |
| Regeneron Healthcare Solutions, Inc. | 11 | $210 |
| Amgen Inc. | 10 | $181 |
| JAZZ PHARMACEUTICALS INC. | 3 | $124 |
Products named: TEZSPIRE, DUPIXENT, INSPIRE, NUCALA, Ohtuvayre, Arikayce, OPSUMIT, FASENRA.
Industry payments across MI — which companies pay providers there.
